IL-1F6 Polyclonal Antibody

The protein encoded by this gene is a cytokine that can activate NF-kappa-B and MAPK signaling pathways to generate an inflammatory response. The encoded protein functions primarily in skin and demonstrates increased expression in psoriasis. In addition, decreased expression of this gene has been linked to a poor prognosis in both hepatocellular carcinoma and colorectal cancer patients.

The IL-1F6 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of IL-1F6 protein in various biological samples. This antibody is produced using a polyclonal approach, ensuring a diverse range of antibodies that target different epitopes of the IL-1F6 protein.

IL-1F6, also known as IL-36α, is a member of the interleukin-1 (IL-1) cytokine family and plays a crucial role in the regulation of immune responses and inflammation. It is involved in various physiological and pathological processes, including the development of autoimmune diseases, chronic inflammatory conditions, and cancer.

The IL-1F6 Polyclonal Antibody has been rigorously validated for its specificity and sensitivity through various experimental techniques, including Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assay (ELISA). It exhibits minimal cross-reactivity with other members of the IL-1 cytokine family, ensuring accurate and reliable results.

This antibody is supplied as a purified and lyophilized form, allowing for long-term storage and easy reconstitution. It is compatible with a wide range of sample types, including cell lysates, tissue homogenates, and biological fluids.

The IL-1F6 Polyclonal Antibody is an essential tool for researchers and clinicians studying the role of IL-1F6 in various diseases and therapeutic interventions. Its high specificity, sensitivity, and versatility make it an invaluable asset in the field of immunology and inflammation research.